Table 1 Patient baseline characteristics before first HSA bolus infusion (n = 23).
Category | Median (IQR) |
|---|---|
Age (months) | 9 (6–60) |
Weight (kg) | 7 (5.5–15) |
Severity score (PRISM-III) | 14 (10–18) |
Diagnosis at admission, n (%) | |
1. Congenital heart disease post-surgery | 16 (69.6%) |
2. Heart transplantation | 3 (13%) |
3. Myocarditis | 2 (8.7%) |
4. Septic shock | 2 (8.7%) |
Vasoactive Inotropic Index | 45 (33–57) |
Admission days | 1 (1–6) |
Days of mechanical ventilation | 1 (1–5) |
Days of vasoactive therapy | 1 (0.5–3) |
Right ventricle dysfunction, n (%) | 11 (47.8%) |
Invasive mechanical ventilation, n (%) | 20 (87%) |
Circulatory support, n (%) | 4 (17.3%) |
Continuous renal replacement therapy, n (%) | 2 (8.7%) |
Death, n (%) | 3 (13%) |
Infused boluses per patient, n (%) | |
5. 1 bolus | 9 (39.1%) |
6. 2 boluses | 7 (30.4%) |
7. 3 boluses | 1 (4.3%) |
8. 4 boluses | 2 (8.7%) |
9. 6 boluses | 2 (8.7%) |
10. 8 boluses | 1 (4.3%) |
11. 10 boluses | 1 (4.3%) |
